Jennison Associates LLC Has $82.50 Million Stake in Agilent Technologies, Inc. $A

Jennison Associates LLC raised its position in Agilent Technologies, Inc. (NYSE:A) by 85.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 606,316 shares of the medical research company’s stock after purchasing an additional 279,759 shares during the period. Jennison Associates LLC’s holdings in Agilent Technologies were worth $82,501,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Board of the Pension Protection Fund acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at about $27,000. Davis Capital Management acquired a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $28,000. Physician Wealth Advisors Inc. raised its stake in shares of Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 196 shares during the period. Torren Management LLC acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at about $32,000. Finally, State of Wyoming acquired a new stake in shares of Agilent Technologies in the 2nd quarter valued at about $35,000.

Agilent Technologies Price Performance

NYSE:A opened at $115.57 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The stock’s 50-day simple moving average is $116.34 and its 200 day simple moving average is $132.53. The company has a market cap of $32.66 billion, a P/E ratio of 25.51, a P/E/G ratio of 2.34 and a beta of 1.30. Agilent Technologies, Inc. has a 52-week low of $104.10 and a 52-week high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the previous year, the business posted $1.31 EPS. The company’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st were issued a dividend of $0.255 per share. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.52%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on A. HSBC began coverage on Agilent Technologies in a research report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price on the stock. TD Cowen lowered their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. UBS Group lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Evercore raised Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $155.00 to $160.00 in a research report on Monday, January 5th. Finally, Wells Fargo & Company lowered their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $163.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.